[go: up one dir, main page]

DE60042606D1 - Anti-angiogener zellulärer wirkstoff zur krebsbehanldung - Google Patents

Anti-angiogener zellulärer wirkstoff zur krebsbehanldung

Info

Publication number
DE60042606D1
DE60042606D1 DE60042606T DE60042606T DE60042606D1 DE 60042606 D1 DE60042606 D1 DE 60042606D1 DE 60042606 T DE60042606 T DE 60042606T DE 60042606 T DE60042606 T DE 60042606T DE 60042606 D1 DE60042606 D1 DE 60042606D1
Authority
DE
Germany
Prior art keywords
cancer treatment
cellular agent
angiogenic
angiogenic cellular
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60042606T
Other languages
English (en)
Inventor
Ernest G Hope
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60042606D1 publication Critical patent/DE60042606D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/15—Natural-killer [NK] cells; Natural-killer T [NKT] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
    • A61K2239/57—Skin; melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60042606T 1999-11-24 2000-11-22 Anti-angiogener zellulärer wirkstoff zur krebsbehanldung Expired - Lifetime DE60042606D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16751399P 1999-11-24 1999-11-24
PCT/US2000/032322 WO2001037671A1 (en) 1999-11-24 2000-11-22 Anti-angiogenic cellular agent for cancer therapy

Publications (1)

Publication Number Publication Date
DE60042606D1 true DE60042606D1 (de) 2009-09-03

Family

ID=22607682

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60042606T Expired - Lifetime DE60042606D1 (de) 1999-11-24 2000-11-22 Anti-angiogener zellulärer wirkstoff zur krebsbehanldung

Country Status (10)

Country Link
US (3) US20080248002A1 (de)
EP (1) EP1231840B1 (de)
JP (1) JP2003519473A (de)
AU (1) AU2425801A (de)
CA (1) CA2391434A1 (de)
DE (1) DE60042606D1 (de)
DK (1) DK1231840T3 (de)
ES (1) ES2383418T3 (de)
PT (1) PT1231840E (de)
WO (1) WO2001037671A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2079478A2 (de) * 2006-11-07 2009-07-22 Pervasis Therapeutics, Inc. Materialien und verfahren für behandlung und management von angiogenesevermittelten erkrankungen
CN102428173B (zh) * 2009-03-26 2014-07-30 细胞维护北欧制药公司 Nk细胞的扩增
EP2470644B1 (de) * 2009-08-24 2016-09-21 Baylor College Of Medicine Erzeugung von ctl-linien mit spezifizität gegen mehrere tumorantigene oder mehrere viren
GB201121308D0 (en) 2011-12-12 2012-01-25 Cell Medica Ltd Process
DK3591047T3 (da) 2012-02-09 2022-10-24 Baylor College Medicine Peptidblandinger til generering af multivirale CTL¿er med bred specificitet
EP3018200A1 (de) * 2014-11-07 2016-05-11 Fondazione Matilde Tettamanti e Menotti de Machi Onlus Verbessertes Verfahren zur Erzeugung von genetisch veränderten Zellen
CN113943703A (zh) 2015-09-18 2022-01-18 贝勒医学院 来自病原体的免疫原性抗原鉴定以及与临床效力的相关性
US10821134B2 (en) 2017-05-17 2020-11-03 Board Of Regents, The University Of Texas System BK virus specific T cells
CN106987558B (zh) * 2017-05-31 2019-12-20 东莞市保莱生物科技有限公司 一种cik细胞培养基
CN108853143A (zh) * 2018-07-04 2018-11-23 盛春华 治疗银屑病的免疫细胞制剂、其制备方法及应用
US10772914B1 (en) 2019-04-18 2020-09-15 Baylor College Of Medicine EBV-specific immune cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5173225A (en) * 1990-05-07 1992-12-22 Bowolfe, Inc. Method for making ultra-thin dense skin membrane
US5660827A (en) * 1992-03-05 1997-08-26 Board Of Regents, The University Of Texas System Antibodies that bind to endoglin
WO1999046365A1 (en) * 1998-03-12 1999-09-16 Emory University Methods and compositions for the selective expansion of gamma/delta t-cells
JP2004503463A (ja) * 1998-08-24 2004-02-05 ザ　ボード　オブ　トラスティーズ　オブ　ザ　リーランド　スタンフォード　ジュニア　ユニバーシティ 免疫系媒介損傷から器官、組織および細胞を保護するための組成物および方法

Also Published As

Publication number Publication date
CA2391434A1 (en) 2001-05-31
WO2001037671A1 (en) 2001-05-31
EP1231840A4 (de) 2004-09-29
DK1231840T3 (da) 2009-11-23
US20100087001A1 (en) 2010-04-08
AU2425801A (en) 2001-06-04
US20080260701A1 (en) 2008-10-23
JP2003519473A (ja) 2003-06-24
EP1231840B1 (de) 2009-07-22
PT1231840E (pt) 2009-10-26
EP1231840A1 (de) 2002-08-21
US20080248002A1 (en) 2008-10-09
ES2383418T3 (es) 2012-06-21

Similar Documents

Publication Publication Date Title
ATE279190T1 (de) Synergistische zusammensetzungen zur krebsbehandlung
IL251270A0 (en) Cancer treatment
ATE430570T1 (de) Synergistische kombinationstherapie zur krebsbehandlung
ITMI990375A1 (it) Trattamento del cancro co epotiloni
DE60104222D1 (de) Funkrufverfahren zur Mobilkommunikation
FI20000863A0 (fi) Uusi hoitomenetelmä
DE10084903T1 (de) Polyetherpolyurethan
DK1176964T3 (da) Brug af ET743 til behandling af cancer
NO20032122L (no) Forbedret behandling
DE60023454D1 (de) Lagenmaterialen mit tensid-modifizierten chelatbildern behandelt
ES1044448Y (es) Auto-aplicador de vendaje
MXPA03008582A (es) Agentes y metodos para tratamiento de cancer.
DE60042606D1 (de) Anti-angiogener zellulärer wirkstoff zur krebsbehanldung
DE60227963D1 (de) Behandlungssystem
DE60135248D1 (de) Immuntherapeutische kombinationen zur tumorbehandlung
DE60222664D1 (de) Hautbehandlungsmittel
DE10081194D2 (de) Darreichungsform zur Applikation in Körperöffnungen
ID30377A (id) Metoda pengobatan neurodegenerasi
PT1224181E (pt) Pirrois substituidos uteis como agentes antiproliferativos para o tratamento do cancro
GB0026015D0 (en) Cancer treatment
EP1684795A4 (de) Verfahren und mittel zur behandlung von krebs
ATE286391T1 (de) Synergistische zusammensetzung zur krebsbehandlung
FR2825893B3 (fr) Tunnel de traitement
FI990183A7 (fi) Solukkoradiojärjestelmä
DE60024916D1 (de) Funkgerät

Legal Events

Date Code Title Description
8364 No opposition during term of opposition